Abstract
Staphylococcal superantigens (SAgs) comprise a large family of exotoxins produced by Staphylococcus aureus strains. These exotoxins are important in a variety of serious human diseases, including menstrual and nonmenstrual toxic shock syndrome (TSS), staphylococcal pneumonia and infective endocarditis, and recently described staphylococcal purpura fulminans and extreme pyrexia syndrome. In addition, these SAg exotoxins are being increasingly recognized for their possible roles in many other human diseases, such as atopic dermatitis, Kawasaki syndrome, nasal polyposis, and certain autoimmune disorders. To clarify the full spectrum of human diseases caused by staphylococcal SAgs, it is necessary to have assays for them. At present there are 23 characterized, serologically distinct SAgs made by S. aureus: TSS toxin-1(TSST-1); staphylococcal enterotoxins (SEs) A, B (multiple variant forms exist), C (multiple minor variant forms exist), D, E, and G; and SE-like H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, and X. The most straightforward way to analyze S. aureus strains for SAgs is through polymerase chain reaction for their genes; we provide here our method for this analysis. Although it would be ideal to confirm that all of the same SAgs are produced by S. aureus strains that have the genes, antibody reagents for SAg detection are only available for TSST-1; SEs A–E and G; and enterotoxin-like proteins H, I, Q, and X. We provide a Western immunoblot procedure that allows in vitro quantification of these SAgs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
(1999) From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. JAMA 282:1123–1125
Bergdoll MS, Crass BA, Reiser RF et al (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1:1017–1021
Bernstein JM, Ballow M, Schlievert PM et al (2003) A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 17:321–326
Blomster-Hautamaa DA, Schlievert PM (1988) Preparation of toxic shock syndrome toxin-1. Methods Enzymol 165:37–43
Kravitz G, Dries DJ, Peterson ML et al (2005) Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 40:941–947
Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520–532
McCormick JK, Yarwood JM, Schlievert PM (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55:77–104
Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16–34
Schlievert PM (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1(1149):1150
Schlievert PM, Shands KN, Dan BB et al (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 143:509–516
Schlievert PM, Tripp TJ, Peterson ML (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000–2003 surveillance period. J Clin Microbiol 42:2875–2886
Lina G, Bohach GA, Nair SP et al (2004) Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis 189:2334–2336
Jarraud S, Cozon G, Vandenesch F et al (1999) Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol 37:2446–2449
Fey PD, Said-Salim B, Rupp ME et al (2003) Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:196–203
Davis JP, Chesney PJ, Wand PJ et al (1980) Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303:1429–1435
Shands KN, Schmid GP, Dan BB et al (1980) Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303:1436–1442
Todd JK, Kapral FA, Fishaut M et al (1978) Toxic shock syndrome associated with phage group 1 staphylococci. Lancet 2:1116–1118
Parsonnet J (1998) Case definition of staphylococcal TSS: a proposed revision incorporating laboratory findings. Int Congr Symp Ser 229:15
Reingold AL, Hargrett NT, Dan BB et al (1982) Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med 96:871–874
MacDonald KL, Osterholm MT, Hedberg CW et al (1987) Toxic shock syndrome: a newly recognized complication of influenza and influenza like illness. JAMA 257:1053–1058
Cone LA, Woodard DR, Byrd RG et al (1992) A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 165:638–643
Hofer MF, Harbeck RJ, Schlievert PM et al (1999) Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol 112:171–176
Hofer MF, Lester MR, Schlievert PM et al (1995) Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Allergy 25:1218–1227
Jackow CM, Cather JC, Hearne V et al (1997) Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion [published erratum appears in Blood 1997 89:3496]. Blood 89:32–40
Leung DY, Meissner HC, Fulton DR et al (1993) Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342:1385–1388
Bohach GA, Fast DJ, Nelson RD et al (1990) Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 17:251–272
Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248:705–711
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Salgado-Pabón, W., Case-Cook, L.C., Schlievert, P.M. (2014). Molecular Analysis of Staphylococcal Superantigens. In: Ji, Y. (eds) Methicillin-Resistant Staphylococcus Aureus (MRSA) Protocols. Methods in Molecular Biology, vol 1085. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-664-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-62703-664-1_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-663-4
Online ISBN: 978-1-62703-664-1
eBook Packages: Springer Protocols